CLINICAL_TRIALS
trial_result
· 2014-06-06
Clinical Trial Update: Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) [Phase 3]
Summary
Phase 3 fixed-dose efficacy and safety trial of asenapine for schizophrenia in adolescents has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Schizophrenia, Paranoid, Schizophrenia, Disorganized | Phase 3 | Status: COMPLETED | Results posted: 2014-06-06